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Abstract 
During the perinatal adaptation process N2BA titin isoforms are switched for N2B titin 
isoforms leading to an increase in cardiomyocyte passive tension (Fpassive). Here we attempted 
to reveal how titin isoform composition and oxidative insults (i.e. sulfhydryl (SH)-group 
oxidation or carbonylation) influence Fpassive of left ventricular cardiomyocytes during rat 
heart development. Moreover, we also examined a hypothetical protective role for titin 
associated small heat shock proteins (sHSPs), Hsp27 and αB-crystallin in the above processes. 
Single, permeabilized left ventricular (LV) cardiomyocytes of the rat (at various ages 
following birth) were exposed either to 2,2’-dithiodipyridine (DTDP) to provoke SH-
oxidation or Fenton reaction reagents (iron(II), hydrogen peroxide (H2O2), ascorbic acid) to 
induce protein carbonylation of cardiomyocytes in vitro. Thereafter, cardiomyocyte force 
measurements for Fpassive determinations and Western immunoblot assays were carried out for 
the semiquantitative determination of oxidized SH-groups or carbonyl-groups of titin 
isoforms and to monitor sHSPs’ expressions. DTDP or Fenton reagents increased Fpassive in 0- 
and 7-day-old rats to relatively higher extents than in 21-day-old and adult animals. The 
degrees of SH-group oxidation or carbonylation declined with cardiomyocyte age to smiliar 
extents for both titin isoforms. Moreover, the above characteristics were mirrored by 
increasing levels of HSP27 and αB-crystallin expressions during cardiomyocyte development. 
Our data implicate a gradual build-up of a protective mechanism against titin oxidation 
through the upregulation of HSP27 and αB-crystallin expressions during postnatal 
cardiomyocyte development. 
Keywords: passive tension, titin isoform, oxidation, carbonylation, modifications, isolated 
cardiomyocytes, heat shock protein  
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Introduction 
Transition from fetal to adult myocardium is coupled to specific changes in the expression 
pattern of sarcomeric protein isoforms, e.g. troponin-I and troponin-T [1-3], α-actin [4], 
myosin heavy chain [5] and titin [6, 7], in association with developmental changes in cardiac 
function [8, 9]. In this context, the biophysical characteristics of titin are considered to be 
decisive for the viscoelastic properties of the sacromere [10, 11]. Titin is a big protein, 
spanning a sarcomere from Z-disc to M-line, it may contain as many as 34.350 amino acids 
correponding to a molecular weight up to 3800 kDa [12]. Titin is encoded by a single gene of 
363 exons with a molecular weight of ~3000-3800 kDa [13]. In mammalian hearts two titin 
isoforms are coexpressed resulting from multiple alternative splicing steps: the smaller and 
stiffer N2B (~3000 kDa) and larger, more compliant N2BA isoform (~3200-3800 kDa) [14]. 
In newborns, a highly compliant large fetal N2BA-type titin isoform is also expressed, and 
together with the N2BA isoform, they are gradually repleaced by the stiffer N2B isoform [6]. 
The N2BA titin isoform contains 513 cysteins whereas the N2B isoform contains 355 cysteins 
[15]. 
 Oxidative modification of proteins by reactive oxygen species (ROS) range from 
protein fragmentation to different types of posttranslational modifications [16-18]. ROS 
induced contractile dysfunctions [19-22] have been implicated in different cardiovascular 
diseases including chronic heart failure [23, 24], myocardial ischemia and reperfusion [25], 
diabetic cardiomyopathy [26], and cardiac hyperthrophy [27, 28]. Titin oxidation modulates 
diastolic stiffness [29] through specific chemical changes of titin amino acid residues in a 
process depending on the chemical characteristics of the oxidative agent together with the 
three dimensional conformation of the interacting titin domains. For example, oxidation of six 
cysteinyl SH-groups resulted in three disulphide bridges in the cardiac specific N2B-unique 
sequence (N2-Bus) in titin, thereby increasing the rigidity of titin and cardiomyocyte passive 
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tension (Fpassive) [30]. Exposures of human permeabilized cardiomyocytes to the SH-oxidant 
2,2'-dithiodipyridine (DTDP) also increased cardiomyocyte Fpassive [20]. Conversely, S-
glutathionylation of cryptic cysteines in Ig domains of the I-band region of titin resulted in a 
substantial drop in Fpassive in overstreched sarcomeres (i.e. at a sarcomere length of 2.6-2.7 
µm) [22]. Protein carbonylation - the commonly considered biomarker of oxidative stress [31] 
- may also bear with functional consequence on sarcomeric funtion [32-34]. Protein 
carbonylation of lysine, arginine, proline or threonine residues develops in response to a 
hydroxyl radical mediated reaction involving reactive aldehydes (or ketones), through the 
participation of hydrogen peroxide (H2O2) and iron(II) (i.e. Fenton reaction) [35-37]. 
Interestingly, similarly to the in vitro effects of DTDP, incubations in the presence of Fenton 
reagents also increased Fpassive of human cardiomyocytes [38].  
Recently it has been revealed that titin function is not only regulated by direct (i.e. 
posttranslational modifications of titin itself) but also by indirect mechanisms in the heart. In 
particular, two small heat shock proteins (sHSPs), the HSP27 and αB-crystallin contributes to 
the regulation of Fpassive. sHSPs translocate to I-band region of titin springs and contribute to 
the maintaince of normal Fpassive under a variety of pathophysiological conditions [39]. Over 
the last decade studies have also addressed the influnce of age and oxidative stress on the 
function of HSPs [40, 41]. 
 Here we focused on titin oxidation and changes in Fpassive of developing 
cardiomyocytes and related the mechanical alterations to titin isoform expressions/oxidations 
and to sHSPs expression. SH-specific oxidation or carbonylation were provoked by the SH-
specific oxidative agent, DTDP or Fenton reagents in vitro. Dithiothreitol (DTT) was used to 
test reversibility. Fpassive was determined before and after exposures to oxidative and reducing 
agents in permeabilized cardiomyocyte-sized preparations of 0-, 7-, 21-day-old and adult (8-
week-old) healthy rats at a wide range of sarcomere lengths. Finally, biochemical and 
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immunohistochemical assays were performed to correlate the age-dependent characteristics of 
titin isoform and sHSPs expressions with those of oxidative Fpassive changes. 
 Our results revealed the existince of an age-dependent protective mechanism to 
maintain physiological Fpassive under oxidative stress which was apperently mediated by 
changes in the expression of sHSPs. 
 
Materials and Methods 
Experimental specimens and ethical statement 
All procedures were approved by the Ethical Committee of the University of Debrecen 
(Ethical Statement No. 24/2013/DE MÁB). Left ventricular (LV) myocardium was collected 
from 0-, 7-, 21-day-old and adult (8 week-old) healthy control Wistar rats. The animals were 
housed in standard cages at 20±2°C controlled room temperatures with natural day and night 
exchange. Standard laboratory chow and tap water were available ad libitum. The hearts were 
quickly excised and the left ventricles were dissected in cold isolating solution (ISO) (1 mM 
MgCl2, 100 mM KCl, 2 mM EGTA, 4 mM ATP, 10 mM imidazole; pH 7.0, 0.5 mM 
phenylmethylsulfonyl fluoride, 40 μM leupeptin and 10 μM E-64, all from Sigma-Aldrich, St. 
Louis, MO, USA), snap frozen in liquid nitrogen, and stored at −80°C. 
 
Passive force measurements in permeabilized cardiomyocytes and in vitro application of 
oxidative and reducing agents 
Deep-frozen LV tissue samples were mechanically disrupted in ISO and thereafter 
permeabilization was performed with 0.5% Triton X-100 detergent for 5 min, as described by 
Papp et al. [42]. Briefly, single permeabilized cardiomyocytes were mounted with silicone 
adhesive (DAP 100% all-purpose silicone sealant; Baltimore, MD, USA) to two stainless steel 
insect needles, which were connected to a sensitive force transducer (SensoNor, Horten, 
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Norway) and to an electromagnetic high-speed lenght controller (Aurora Scientific Inc., 
Aurora, Canada) in ISO at 15°C. Fpassive measurements were performed at sarcomere lengths 
(SLs) of 1.9-2.5 μm in relaxing solution (10 mM N,N-Bis (2-hydroxyethyl)-2-
aminoethanesulfonic acid, 37.11 mM KCl, 6.41 mM MgCl2, 7 mM EGTA, 6.94 mM ATP, 15 
mM creatine phosphate; pH 7.2 all from Sigma-Aldrich, St. Louis, MO, USA) in the presence 
of protease inhibitors: 0.5 mM phenylmethylsulfonyl fluoride, 40 μM leupeptin and 10 μM E-
64. The Ca2+-independent Fpassive was approximated by shortening of the preparations to 80% 
of the original lengths for 8 sec. Fpassive was normalized for the cardiomyocyte cross-sectional 
area, calculated from the width and height of the cardiomyocyte. 
 To modulate the SH-group content or carbonylation status of titin isoforms isolated 
cardiomyocytes were incubated at room temperature in 200 µl relaxing solution supplemented 
with the SH-oxidant DTDP (10 mM, Sigma-Aldrich, St. Louis, MO, USA) for 2 min or 
Fenton reagents (50 µM FeSO4, 1.5 mM H2O2, 6 mM ascorbic acid, Sigma, St. Louis, MO, 
USA) for 7 min at a SL of 2.3 µm. Reversibility of the oxidative effects was tested by the 
sequential application of the thiol-groups reductant  DTT (10 mM, Sigma-Aldrich, St. Louis, 
MO, USA) for 30 min. 
 
Sodium dodecyl sulfate-polyacrilamid gel electrophoresis (SDS-PAGE) 
Agarose-strengthened 2% SDS-polyacrilamide gels were used to separate titin isoforms. 
Separation of myosin heavy chain (MHC) small heat shock proteins (HSP27 and αB-
crystallin) or myocardial porteins with relatively low molecular weights were carried out in 
4%, 8% or 12% polyacrilamide gels. Proteins were visualized by Coomassie blue staining or 
by Western immunoblotting. 
 
Ellman's reaction 
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Myofilament SH-group contents were determined by the Ellman’s reaction. Permeabilized LV 
cardiomyocytes were treated with ISO (time control) or with ISO supplemented with DTDP 
and DTT as described for the functional and biochemical experiments. Protein homogenates 
were washed and incubated with the Ellman’s reagent for 15 min at RT (5,5′-dithiobis(2-
nitrobenzoic acid Sigma–Aldrich, St. Louis, MO, USA), which reacts with protein SH groups 
and produces yellow 2-nitro-5-thiobenzoic acid (NTB). The absorbance of NTB was 
measured by a NOVOStar microplate reader (BMG Labtech GmbH, Offenburg, Germany) at 
412 nm. N-acetyl-l-cysteine (NAC; Sigma–Aldrich, St. Louis, MO, USA) was used to 
calibrate the NTB absorbance in relation to the amount of SH groups. The calibration curves 
were fitted to a single exponential, and SH-groups contents of LV heart samples were 
calculated. Measurements were performed in triplicate. 
 
Determination of SH-group oxidation in titin isoforms 
Cardiomyocytes were treated in relaxing solution containing DTDP (10 mM, for 2 min) or 
DTT (10 mM, for 30 min). Reduced SH-groups of titin isoforms of cardiomyocytes were 
labeled by EZ-Link Iodoacetyl-LC-Biotin or biotin-iodoacetamide (BIAM) (Thermo 
Scientific, Rockford, IL, USA, for 60 min in darkened conditions at room temperature) in a 
reaction buffer (containing 5 mM EDTA, 50 mM Tris–HCl, pH 8.3 and 0.1 mg/ml biotin) 
according to the manufacturer’s instructions (biotin was dissolved in dimethyl formamide 
(Sigma-Aldrich, St. Louis, MO, USA) and diluted in reaction buffer to 0.1 mg/ml). After 
biotinylation, proteins of permeabilized cardiomyocytes were solubilized in sample buffer 
(containing 8 M urea, 2 M thiourea, 3% (w/v) sodium dodecyl sulfate (SDS), 75 mM DTT, 50 
mM Tris-HCl, pH 6.8, 10% (v/v) glycerol, 0.5% bromophenol blue, 40 µM leupeptin and 10 
µM E-64) [43]. Following 45 min continuous agitation protein concentration was measured 
from the supernatant with a dot-blot based method, where different dilutions from bovine 
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serum albumine (BSA) served as standard, and protein concentration was adjusted to 2 
mg/ml. Following SDS- PAGE proteins were transfered onto an Immobilon-FL PVDF 
membrane (Millipore, Billerica, MA, USA). Membranes were blocked by 2% BSA diluted in 
PBS containing 0.1% Tween 20 (PBST) for 30 min. Biotin-labeled SH-groups were probed 
with phycoerytrin-conjugated (PE) streptavidin (Jackson ImmunoResearch, West Grove, PA, 
USA, cat.no: 016-110-084) during 45 minuntes long incubations. Total protein amounts were 
quantitated with the super sensitive blot staining (UD-GenoMed, Debrecen, Hungary). 
Fluorescent signals were detected with a gel documentation system (MF-ChemiBIS 3.2, DNR 
Bio-Imaging Systems, Jerusalem, Israel), and subsequently normalized for those assessed 
with the super sensitive blot stain. 
 
Determination of titin isoform carbonylation by oxyblot assay 
The carbonyl group content of titin isoforms was determined using an oxyblot protein 
detection kit (Millipore, Billerica, MA, USA). Permeabilized cardiomyocytes were treated in 
200 µl relaxing solution containing Fenton reagents (50 µM FeSO4, 1.5 mM H2O2, 6 mM 
ascorbic acid, Sigma, St. Louis, MO, USA). Cardiomyocytes were solubilized in sample 
buffer (containing 8 M urea, 3% SDS, 50 mM Tris–HCl (pH 6.8), 40 µM leupeptin and 10 
µM E-64), and the carbonyl groups were derivatized to 2,4-dinitrophenylhydrazone (DNPH) 
through a reaction with 2,4-dinitrophenylhydrazine (DNPH). After the derivatization process 
(15 min), samples were centrifuged (1000g for 1 min) and the pellet was dissolved in a 
sample buffer (8 M urea, 2 M thiourea, 3% (w/v) SDS, 75 mM DTT, 50 mM Tris-base (pH 
14), 10% (v/v) glycerol, 0.5% bromophenol blue, 40 µM leupeptin and 10 µM E-64) [43]. 
Protein concentrations of the supernatants were determined by the dot-blot technique using a 
BSA standard and the concentration of samples was adjusted to 2 mg/ml. SDS-PAGE was 
used to seperate the derivatized titin isoforms. After gel electroforesis proteins were 
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transferred onto Immobilon-FL PVDF membrane. Proteins in PVDF membranes were 
visualized with a membrane stain. Then membranes were blocked with 2% (w/v) BSA in 
PBST for 30 min and probed with primary (rabbit anti-DNPH antibody 1:150, 1 h, cat.no: 
S7150) and biotin conjugated secondary antibodies (goat anti-rabbit IgG 1:1000 45 min) 
diluted in 1% (w/v) BSA/PBST. Biotin-labeled carbonyl-groups were probed with 
phycoerytrin-conjugated (PE) streptavidin during 45 minutes long incubations. Bands were 
normalized for those assessed with a super sensitive stain. Data are given relative to signal 
intensities of untreated controls (carbonylation index, CI). 
 
Western immunoblot analysis of HSP27 and αB-crystallin 
Isolated, permeabilized LV cardiomyocytes were used during Western immunoblot analyses. 
Cardiomyocyte proteins were solubilized in SDS sample buffer (Sigma, St. Louis, MO, USA) 
supplemented with 10 µM E-64, and 40 µM leupeptin. Protein concentration was measured 
from the supernatant with the dot-blot based method, as mentioned above, and was adjusted to 
2 mg/ml. Proteins were loaded onto 8% SDS-polyacrylamide gels. Proteins were transfered 
onto nitrocellulose membranes. Membranes were blocked with 5% BSA (Sigma-Aldrich, St. 
Louis, MO, USA) dissolved in PBST and probed with primary (anti-HSP27 (1:300) or anti- 
αB-crystallin (1:1000) Abcam, Cambridge, UK, cat.no: ab2790 and ab76467) and secondary 
antibodies (peroxidase- conjugated goat anti-mouse (1:100000) or goat anti-rabbit (1:300), 
Sigma-Aldrich, St. Louis, MO, USA). Bands were visualized by the chemiluminescence 
(ECL) method. Total protein amounts were quantified with the super sensitive membrane 
stain.  
 
Immunohistochemistry 
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Cardiomyocytes were isolated from frozen LV heart tissues the same way as for the 
functional measurements. Cardiomyocytes were permeabilized in 0.5% Triton X-100 and 
samples were fixed with cold acetone for 10 min and were washed twice with PBS 
(containing 150.7 mM NaCl, 3.22 mM KCl, 0.735 mM KH2PO4, 8.6 mM Na2HPO4; pH 7.4 
all from Sigma-Aldrich, St. Louis, MO, USA) on microscope slides. Then the samples were 
incubated in methanol for 20 min, followed by a washing step with PBS for 5 min and 
blocked in normal goat sera (1.5% in PBS, Sigma-Aldrich, St. Louis, MO, USA) for 20 min. 
Next, tissue samples were incubated with primary antibodies (anti-HSP27 (1:50, Abcam, 
Cambridge, UK, cat.no: ab2790), anti-αB-crystallin (1:300, Abcam, Cambridge, UK, cat.no: 
ab76467) and anti-titin (1:50, T11, Sigma-Aldrich, St. Louis, MO, USA, and T63 by 
Wolfgang A. Linke from Bochum, Germany) diluted in blocking buffer (1.5% goat serum in 
PBS) overnight at 4°C, and thereafter secondary antibodies were applied (goat-anti-rabbit Cy2 
and Cy3 and biotinylated goat-anti-mouse (1:200, Jackson ImmunoResearch, West Grove, 
PA, USA) for 2 h at room temperature. Biotinylated antiobodies were detected by Cy2- and 
Cy3- conjugated streptavidine (1:500, Jackson, Bar Harbor, ME, USA). Images were captured 
by a Scion Corporation (Frederick, MA, USA) digital camera attached to a Nikon Eclipse 80i 
fluorescent microscope (Nikon, Tokyo, Japan). Recorded myocyte images were processed by 
ImageJ software. 
 
Data analysis, statistics 
Fpassive values are expressed in kN/m
2. Signal intensities of protein bands were quantified by 
using the ImageJ, image processing program (National Institutes of Health, Bethesda, 
Maryland, USA) and Magic Plot (Magicplot Systems, Saint Petersburg, Russia) softwares. 
Statistical significance was tested by analysis of variance (ANOVA followed by Bonferroni’s 
post hoc test). GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA, USA) software 
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was used to evaluate the results. Values are given as mean±SEM. The limit for statistical 
significance was P < 0.05. 
 
Results 
1. SH oxidation of titin isoforms increases Fpassive in an age-dependent manner 
Permeablized LV cardiomyocytes of 0-, 7-, 21-day-old, or adult rats were characterized by 
gradually increasing passive stiffness (Fpassive) along with decreasing expression levels of the 
N2BA titin isoform and increasing expression levels of the N2B titin isoform (Supplemantary 
Material, Figure S1) as expected. The concentration dependent effects of DTDP (between 1 
mM and 50 mM) on free SH-group contents of N2BA and N2B titin isoforms and Fpassive were 
screened in permeabilized cardiomyocytes of 7-day-old animals, where we found marked 
responses in the above parameters following incubations in the presence of 10 mM DTDP 
(Supplementary Material, Figure 2S). 
Following exposures to the SH-oxidant DTDP Fpassive increased significantly in all age-
groups, but to relatively higher extents in the newborn (0-day-old) and 7-day-old age groups 
than in the 21-day-old and adult age groups (Fpassive changed from 0.09±0.02 kN/m
2 to 
0.18±0.03 kN/m2 in the newborn group; from 0.19±0.02 kN/m2 to 0.31±0.04 kN/m2 in the 7 
day-old age group; from 0.45±0.07 kN/m2 to 0.60±0.07 kN/m2 in the 21 day-old group and 
from 2.35±0.11 kN/m2 to 2.76±0.16 kN/m2 in cardiomyocytes of adult rats, SL: 2.3 µm, 
P<0.05 vs. control in all age groups, n=6-8 cardiomyocytes from at least three different hearts, 
Figure 1). DTT was applied after DTDP treatments to test the reversibility of SH oxidation. 
DTDP mediated increases in Fpassive were reversed upon DTT treatment in all age groups 
(Fpassive following DTT were: 0.10±0.01 kN/m
2; 0.21±0.02 kN/m2; 0.51±0.08 kN/m2 and 
2.28±0.12 kN/m2 in 0, 7, 21 day-old and adult rat cardiomyocytes, respectively, SL: 2.3 µm; 
n=6-8 cardiomyocytes from at least three different hearts; Figure 1). To test a hypothetical SL 
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dependent influence on DTDP-evoked Fpassive changes, 0 day-old and adult cardiomyocytes (7 
cardiomyocytes in both groups) were also exposed to DTDP at a reduced SL (i.e. at 1.9 µm). 
However, increases in Fpassive following DTDP incubations at 1.9 µm or 2.3 µm SLs were 
indistinguishable from each other when tested at a SL of 2.3 µm (P>0.05) in both age groups 
(data not shown). Hence, these experitments argued against a hypothetical SL dependent 
effect of DTDP (within a range of SLs between 1.9 µm and 2.3 µm). 
 A biotinylation-based assay was included to evaluate the SH oxidative changes of 
N2BA and N2B titin isoforms following DTDP exposures. DTDP decreased the free SH-
group content of N2BA and N2B titin isoforms by similar extents (normalized SH-group 
content: 100% before DTDP exposures; control) in permeabilized cardiomyocytes of the 0-, 
7-, 21-day-old and adult age groups (i.e. by: 80±1%, 71±1%, 64±1% and NA in the N2BA 
titin isoform; and by: 74±1%, 62±2%, 53±2% and 32±2% in the N2B titin isoform; P<0.05 vs. 
control, for the above age groups, respectively, n=8-23 independent determinations, Figure 2). 
The free SH-group content of N2BA titin isform in the adult age group could not be assessed 
(NA) due to the low expression level of this titin isoform. Free SH-group sensitive signal 
intensities returned to control levels following DTT applications, moreover, DTT alone had 
no effect on cardiomyocyte SH-group oxidation (Figure 2). Figure S3A illustrates the SH-
contents of the two titin isoforms in control and DTDP-treated cardiomyocytes in blots 
including all four age groups. In this study, functional and biochemical studies were 
performed in defrosted permeabilized cardiomyocytes from animals of different age groups. 
Using the SH-sensitive Ellman's reaction and biotinylation assays revealed no statistically 
significant differences between the free SH-contents of frozen/thawed and freshly isolated 
samples (Supplementary Material, Figure S4). Results of additional assays by the SH-
sensitive biotin-iodoacetamide (BIAM) [44] gave qualitatively similar results (Supplementary 
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Material, Figure S5) to those obtained by EZ-Link-Iodoacetyl-LC-Biotin (Figures 2, S3A, 
S4A, S6A). 
 
2. Carbonylation of titin isoforms increases Fpassive in an age-dependent manner 
The effects of protein carbonylation on Fpassive were investigated in permeabilized LV 
cardiomyocytes in different age groups following incubations in the presence of Fenton 
reagents. Similarly as above, attempts were made to reverse the Fenton effects by the 
application of DTT. Figure 3 illustrates that Fenton reagents increased Fpassive significantly in 
0-, 7-, 21-day-old and adult groups, but gradually to less and less relative extents with 
cardiomyocyte age (i.e. to: from 0.11±0.01 kN/m2 to 0.22±0.01 kN/m2 in 0-day-old, from 
0.26±0.02 kN/m2 to 0.44±0.05 kN/m2 in 7-day-old, from 0.49±0.03 kN/m2 to 0.69±0.06 
kN/m2 in 21-day-old, from 2.17±0.05 kN/m2 to 2.59±0.10 kN/m2 in adult rats, respectively, 
P<0.05 vs. control, n=6-7 cardiomyocytes from at least three different hearts). Moreover, the 
above mechnical effects were fully reversed by the application of DTT in the 0-,7- and 21-
day-old groups, but not in adult group (Fpassive: 0.11±0.01 kN/m
2; 0.22±0.02 kN/m2; 
0.35±0.03 kN/m2 and 2.94±0.15 kN/m2, in the above age groups, respectively, P<0.05 vs. 
control, n=6-7 cardiomyocytes from at least three different hearts).  
 In paralell biochemical investigations oxyblot assays were performed to reveal the 
extents of carbonyl group formations of N2BA and N2B titin isoforms in myocardial tissue 
homogenates following incubations in the presence of Fenton reagents. Figure 4 illustrates 
that the levels of carbonyl groups (carbonylation index of untreated control: 1 AU) increased 
significantly following exposures to Fenton reagents, although in an apparent negative 
correlation with age (i.e. to 2.57±0.06 AU, 2.37±0.02 AU, 1.35±0.03 AU, in 0-, 7-, 21-day-
old cardiomyocytes, respectively, in N2BA titin isoforms; and to: 2.90±0.10 AU, 2.57±0.04 
AU, 1.79±0.03 AU, 1.51±0.02 AU, in 0-, 7-, 21-day-old and adult cardiomyocytes, 
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respectively, in N2B titin isoforms, P<0.05, n=9-18 independent determinations from at least 
three different hearts, Figure 4). Protein carbonylation of the N2BA titin isform in the adult 
age group could not be assessed due to the low expression level of this titin isoform. Titin 
carbonylations were generarly reversed by DTT, except in adult cardiomyocytes. Figure S3B 
illustrates the carbonylations of the two titin isoforms of control and Fenton-treated 
cardiomyocytes in blots including all four age groups. Figure S6B illustrates the age 
dependence of protein carbonylation for additional myofilament proteins. 
 
3. Gradual increases in the expression levels of HSP27 and αB-crystallin proteins in 
developing cardiomyocytes 
To characterize the levels of HSP27 and αB-crystallin expressions in permeabilized 
cardiomyocytes tissue homogenates from 0-, 7-, 21-day-old and adult rat hearts were analyzed 
by Western immunblotblotting. These investigations revealed, that the relative expression 
levels of HSP27 (1.04±0.08 AU, 2.14±0.30 AU, 3.04±0.49 AU, 4.83±0.54 AU in 0-, 7-, 21-
day-old and adult rats, respectively, P<0.05 vs. day 0 (d0, reference level:1), n=9-17 
determinations from at least three different hearts; Figure 5A), and αB-crystallin (1.00±0.11 
AU, 1.61±0.19 AU, 3.23±0.86 AU, 4.42±0.96 AU in 0-, 7-, 21-day-old and adult rats, 
respectively, P<0.05 vs. d0, n=8-15 determinations from at least three different hearts; Figure 
6B) gradually increased with cardiomyocyte age. Figure 5C illustrates the increasing levels of 
sHSPs compared to the amounts of titin isoform expressions (total titin) during cardiac 
developement. (Expression levels of both sHSPs were normalized to actin expression, while 
relative titin levels are given relative to MHC expression. The ratio of MHC to actin 
expression appeared to be constant in all age groups (data not shown). 
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 In accordance with the biochemical data, immunohistochemical staining of LV 
cardiomyocytes revealed progressive HSP27 and αB-crystallin expressions with remarkbale 
colocalizations with titin proteins during cardiomyocyte maturation (Figure 6). 
 
4. Correlations between oxidative changes of cardiomyocyte Fpassive, oxidative changes of titin 
isoforms and expression levels of HSP27 and αB-crystallin during cardiomyocyte 
development 
Strong negative correlations were noted when protein oxidation evoked changes in Fpassive, 
oxidized SH contents or carbonylation indices of titin isoforms were contrasted to the 
expression levels of HSP27 or αB-crystallin at different cardiomyocyte ages (Figure 7). 
 
Discussion 
Major novelties of the present study are that titin oxidation and carbonylation have similar 
effects on N2BA and N2B titin isoforms, and myofibrillum associated heat shock proteins 
(HSP27 and αB-crystallin) may confer protection against the above forms of oxidative 
modifications. Interestingly, this putative HSP-mediated protection builds up gradually with 
postnatal cardiomyocyte age, without the influence of experimental stress of any forms (i.e. in 
control, untreated animals). 
 In this study, Fpassive was probed by exposures to oxidative agents in isolated, 
permeabilized cardiomyocytes at physiologically relevant sarcomere lengths and at various 
postnatal developmental stages. This approach also allowed the investigation of a hypothetical 
link between titin isoform oxidation and sHSPs (i.e. HSP27 and αB-crystallin) expression. 
Here we report that cardiomyocyte development is accompained by a gradual decline in the 
sensitivity of both N2BA and N2B titin isoforms to oxidative challenges, and consequently 
Fpassive became more and more resistant against oxidative insults in developing 
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cardiomyocytes. This finding implicates the build up of a protective mechanism against titin 
oxidation (not discriminating between the two titin isoforms) during postnatal cardiomyocyte 
maturation. 
 Our present data on the relationship between titin isoform switching and Fpassive 
production are consistent with those of earlier investigations [45] [6]. Fpassive increased with 
cardiomyocyte age at a wide range of sarcomere lengths due to an increase in the N2B/N2BA 
titin isoform expression ratio together with increases in total sarcomeric titin expression. To 
compensate for the effects of changes in total titin expression DFpassive has been normalized 
for baseline Fpassive when the mechanisms of oxidative challenges were analyzed. Besides titin 
isoform composition [46] cardiomyocyte Fpassive can be also increased by dephosphorylation 
([47]) and oxidation (including SH-group oxidation [30], and carbonylation [38]) of titin 
isoforms. Nevertheless, till now little information became available on the oxidation of titin 
isoforms and on their functional consequences in the developing heart. 
 In our present work, SH-group oxidation of titin isoforms was provoked by an SH-
group specific oxidative agent, DTDP in vitro. DTDP can react and oxidize thiol groups of 
proteins, thereby generating intra- or intermolecular disulfide bridges or mixed disulfides 
between the cysteinil residues and one-half of the DTDP molecules [48]. We observed that 
the DTDP evoked increments in Fpassive (when normalized for baseline Fpassive) declined with 
age in permeabilized cardiomyocytes of the rat in a reversible fashion. Moreover, the extent 
of DTDP evoked SH-group oxidation also declined with age in both N2BA and N2B titin 
isoforms (Figure 8). To avoid aspecific reactions with histidyl side chains, pH was set to 8.3 
during SH-group labelling by EZ-Link-Iodoacetyl-LC-Biotin. It is to be stressed, that at pH 
8.3 more thiols are labelled by EZ-Link-Iodoacetyl-LC-Biotin than those being sensitive to 
oxidation at a lower pH, and consequently this approach represents a limitation from a 
quantitative viewpoint. Nevertheless, results of additional assays where reactive cysteine 
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thiols were specifically labelled by BIAM at pH 6.5 were consistent with those obtained by 
EZ-Link-Iodoacetyl-LC-Biotin labelling, thereby confirming the main finding of this work on 
the age dependent decline in oxidant sensitive thiol contents of the two titin isoforms. 
 In addition to SH-group oxidation, ROS induced myofilament protein carbonylation 
can also contribute to contractile dysfunction in the heart [49]. Hydroxyl radicals are highly 
reactive and thus react with divergent cell components [50]. In this study, Fenton reagents 
were used to produce hydroxyl radicals and to induce titin carbonylation in vitro. Fenton 
reagents increased Fpassive in all age groups. Moreover, similarly to the effects of DTDP, the 
increases in Fpassive (when normalized for baseline Fpassive) declined with age. Furthermore, the 
extent of titin carbonylation also diminished with age (Figure 8). Interestingly, DTT 
exposures following Fenton treatments could restore Fpassive in 0-, 7- and 21-day-old 
cardiomyocytes, but not in adult cardiomyocytes. Moreover, carbonyl content mirrored these 
mechanical effects. These findings are consistent with those of Wong et al. who reported that 
carbonylated protein content can be decreased by thiol-group reductants resulting in protein 
decarbonylation [51, 52]. 
 Taken together, for oxidative challenges of identical strengths, the extents of titin SH-
oxidations or carbonylations declined with age for both titin isoforms. This effect apparently 
did not depend on the N2B/N2BA titin isoform expression ratio and paralleled the changes of 
normalized DFpassive, suggestive for a cause-effect relationship. Moreover, these findings are 
also suggestive for a gradual decline in the oxidative sensitivities of cardiomyocyte Fpassive 
with cardiomyocyte maturation. Interestingly, for a given DFpassive the involvements of titin 
isoforms by SH-oxidation or carbonylation were remarkably similar (Figure 8). Collectively, 
these findings implicated the gradual build up of a protective mechanism being irrespective to 
the chemical nature of oxidative insults (i.e. SH-oxidation vs. protein carbonylation) or to titin 
isoform expression. 
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 Previous experimental studies furnished with evidence on the protective roles for 
sHSPs for sarcomeric proteins such as actin, desmin, myosin, tropinin-I, troponin-T and titin 
[53-56]. sHSPs have been implicated in promoting physiological protein folding and 
preventing misfolding, thereby protecting the function of native macromolecules, and limiting 
the effects of oxidative stress in general [57]. In the above context misfolded proteins have 
been associated with higher sensitivities for carbonylation than those of their native forms 
[31]. Two myocardial sHSPs, HSP27 and αB-crystallin are known to be induced by heat 
stress, ageing, end-stage heart failure or ishemic injury [58, 59]. Moreover, these proteins are 
also known to be involved in preventing the effects of oxidative stress [60] and in the 
regulation of cellular redox states [61]. Although many sHSPs are associated with sarcomeric 
proteins, it has been postulated that HSP27 is not bound to actin, actin linked proteins, myosin 
or desmin in zebrafish cardiomyocytes [62]. However, HSP27 and αB-crystallin can both 
colocalize with I-band titin in cardiac and skeletal muscles, translocate and bind to the spring 
elements of titin isoforms under stress conditions [39] [56]. A potential contribution of sHSPs 
to normal passive elasticity and a role in the maintenance of normal function of cardiac and 
skeletal muscles have been also implicated [39, 56, 63, 64]. Interestingly, Kötter et al. 
demonstrated that the interaction between titin and sHSPs is enhanced by the expression of 
the N2B titin isoform. Consistently, we found strong co-localiozation between sHSPs and the 
sarcomeric cross striation pattern at more advanced ages when N2B titin isoform expression 
was high [39]. Moreover, it has been argued, that in the presence of sHSPs, Ig domains of titin 
are prevented from unfolding [56] and that the unfolded Ig regions of titin (disordered titin 
spring elemnts: N2-Bus and PEVK) are probably protected against aggregation [39]. In 
neonatal cardiomyocytes the more compliant N2BA is the dominant isoform, and sHSPs 
might not bind efficiently to compliant titin [39]. Accordingly, we could not find prominent 
co-localization between sHSPs and titin in neonatal cardiomyocytes, thereby hypothetically 
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leaving more functional groups of titin molecules accessible for oxidative insults. Our present 
findings extend the above observations, and suggest that the increase in sHSPs expression can 
gradually outweight the increase in titin expression during cardiomyocyte development, 
thereby increasing the probability for interactions between sHSPs and titin isoforms. 
Moreover, our data did not support major distinctions between the oxidative characteristics of 
N2BA and N2B titin isoforms. Based on remarkably pronounced correlations between the 
expression levels of HSP27 and αB-crystallin and oxidative changes in mechanical 
characteristics of cardiomyocytes (i.e. in Fpassive) and biochemical (i.e. SH oxidation or 
carbonylation) properties of titin isoforms, we postulate a link between the oxidative 
sensitivities of titin isoforms and the expression levels of HSP27 and αB-crystallin. 
 Sarcomeric protein oxidation is the function of chemical and spatial characteristics of 
the employed oxidative agent and of the interacting proteins. In this context SL appears as a 
crucial determinant for titin oxidation by modulating exposures of oxidation sensitive amino 
acid residues through protein folding/unfolding [22]. In this study, mechanical responses on 
SH-group oxidation where not different when cardiomyocytes of newborn and adult rats were 
exposed to DTDP at a SL of 1.9 µm or 2.3 µm, suggesting that in this range of SLs the above 
effect had negligable influence. Nevertheless, we cannot exclude that oxidative manipulations 
by other oxidative agents and at higher sarcomere lengths than employed here may expose 
additional, so called cryptic cysteinil residues of titin isoforms thereby leading to distinct 
functional effects. The hypothetical involvement of sHSPs in preventing the oxidation of titin 
isoforms is supported only by correlative associations here, and hence we have to stress that 
additional molecular mechanisms can be also involved in the above processes. 
 In summary, this work implicated relationships between titin isoform oxidation, 
cardiomycyte Fpassive and HSP27/αB-crystallin expression in the developing rat heart. Two 
different types of oxidative modifications: SH-group oxidation and carbonylation of titin 
20 
 
isoforms influenced Fpassive of cardiomyocytes in a similar fashion suggesting common 
molecular mechanisms for their coordinated effects. Our data suggest that during cardiac 
development the oxidative sensitivity of titin-based Fpassive declines due to the build-up of a 
protective mechanism preventing the oxidation of titin. We propose that this protection is 
mediated (at least in part) by sHSPs, such as HSP27 and αB-crystallin. 
 In this investigation we focused on titin, which is probably the most important 
determinant of cardiomyocyte Fpassive. The employed oxidative interventions were arbitrarily 
set to levels severe enough to provoke significant changes in cardiomyocyte Fpassive, and to 
allow quantification of titin alterations from technically challenging gel procedures. One may 
argue that under these conditions several cardiomyocyte proteins are affected, and therefore 
the recorded mechanical alterations might be complemented by protein changes other than 
titin. As a matter of fact, age-dependent characteristics appeared to be similar to those of the 
two titin isoforms for some (e.g. at the molecular weights of MHC, α-actinin, actin and MLC), 
but not all cardiomyocyte proteins (e.g. at the molecular weights of desmin, tropomyosin and 
cTnI). In addition, age dependent oxidant sensitivity of reactive thiols may also be the 
function of thiol:protein abundance ratio, a paramater not systematically screened here. It is 
clear from the above limitations, that further efforts are needed to address the age dependence 
of cardiomyocyte protein oxidation and their contribution to cardiomoycyte function under 
more physiological conditions. An additional major limitation of our study is that we have not 
employed a model system where plasmid- or virus-mediated HSP27 or αB-crystallin are 
overexpressed in a controlled way, and the impact of this on titin oxidation is determined. An 
interventional study such as this one may help address this major limitation. 
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Figure legends 
 
Figure 1. Effects of DTDP on cardiomyocyte Fpassive generation in different age groups. 
Bar graphs illustrate the magnitudes of changes in Fpassive after DTDP treatments (10 mM) in 
permeabilized cardiomyocytes of 0- (A), 7- (B), 21-day-old (C) and adult (D) animals 
followed by the application of the thiol-group reductant DTT (10 mM) (n=6-8 
cardiomyocytes in each group) at a sarcomere length of 2.3 µm. Data are expressed as 
mean±SEM, *P<0.05 vs. control. 
 
Figure 2. DTDP-induced SH-group oxidation of titin isoforms during postnatal heart 
development. After DTDP treatments, free SH-group content of N2BA and N2B titin 
isoforms was determined by a biotinylation assay and total protein content of proteins were 
quantitated with blot staining in all groups. The ratios of the optical densities of the bands 
(free SH-group content/total protein) were normalized to untreated control for each membrane 
(n=10-16 hearts). T2 is a degradation product of titin, that mainly contains the A-band 
segment of titin [6]. Symbols illustrate means±SEM, *P<0.05 in all graphs vs. csontrol (A-D). 
SH-group oxidatin of N2BA titin isoform could not be detected in adult rat cardiomyocytes 
due to its low expression level (D). Discontinuities within the membranes are signified by 
continous lines. 
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Figure 3. The effects of protein carbonylation on Fpassive in cardiomyocytes in different 
age groups. Fpassive in LV cardiomyocytes were determined in relaxing solution before 
(control), after exposures to Fenton reagents (Fenton) in the four age-groups (n=6-7 
cardiomyocytes in each group), and after incubations in the presence of DTT (10 mM) (A-D). 
Data are expressed as mean±SEM, *P<0.05 vs. untreated control. 
 
Figure 4. Fenton reaction-induced carbonylation of titin isoforms during postnatal heart 
development. Myocardial samples of different age groups were exposed to Fenton reagents in 
relaxing solution and protein carbonylation was subsequently assayed by the oxyblot method 
(n=9-16 hearts). Total protein amounts were determined with blot staining. Carbonylation is 
given in relative terms as carbonylation index (CI = 1, based on signal intensities in relaxing 
solution, control) (A-D). Data are expressed as mean±SEM, *P< 0.05. Carbonylation of the 
N2BA titin isoform could not be detected in adult rat cardiomyocytes due to its low 
expression level (D). 
 
Figure 5. The expression levels of HSP27 and αB-crystallin increase during cardiac 
development. Representative examples of Western immunoblot assays demonstrate the 
expression levels of HSP27 (A) and αB-crystallin (B) in permeabilized cardiomyocytes 
during rat heart development. HSP27 and αB-crystallin were labelled with specific antibodies 
and actin was visualized by blot staining following its identification based on its molecular 
mass. Both sHSPs amounts were contrasted to the expression levels of actin. The expression 
levels of total titin isoforms (same data as in Figure S1D), HSP27 and αB-crystallin were also 
contrasted to each other as a function of cardiomyocyte age (C). Symbols illustrate 
means±SEM, and asterisks (*) depict significant differences vs. 0-day-old rat hearts (Control) 
(n=6-8 hearts). 
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Figure 6. Binding of HSP27 and αB-crystallin to titin molecules. Cardiomyocytes of 
different age groups were labeled with ant-titin T11 (green) and anti-HSP27 (red) (A) or titin 
T63 (green) and anti-αB-crystallin (red) antibodies (B). Cy2- or Cy3-conjugated secondary 
antibodies were used for development. Merged images are given in the right columns. Similar 
observations were obtained in four independent immunohistochemical assays. 
 
Figure 7. Expression levels of sHSPs correlated with oxidative changes in Fpassive and 
oxidative modifications of titin isoforms. Strong correlations were found between the 
expression levels of HSP27 or αB-crystallin and ΔFpassive of DTDP- or ΔFpassive of Fenton-
treated cardiomyocytes (A-D). The oxidized SH contents and carbonylation indices of N2B 
and N2BA titin isoforms correlated reasonably with the expression levels of HSP27 or αB-
crystallin in all groups. (E-H). Correlations were assessed by approximating the values by 
linear regression. Data points represent means±SEM. 
 
Figure 8. Relative extents of DTDP-evoked or Fenton-evoked changes in cardiomyocyte 
Fpassive values together with oxidized SH-groups or carbonyl contents of titin isoforms in 
developing rat hearts. Cardiomyocyte Fpassive values (expressed relative to the control values 
following DTDP or Fenton treatments in the four age groups, see Figure 1 and Figure 3 for 
absolute values) illustrate gradually decreasing oxidative sensitivities for developing 
cardiomyocytes following birth (DFpassive of DTDP: 99±26 % in 0-, vs. 65±23 % in 7-, vs. 
39±21 % in 21-day old and 18±7 % in adult groups. DFpassive of Fenton: 108±12 %; 69±10 %; 
40±5 % vs. 21±5% 0-, 7-, 21-day-old and adult groups, SL: 2.3µm P<0.05) (A-B). Oxidized 
SH-group contents of N2BA and N2B isoforms were calculated from free SH-group contents 
of titin isoforms (Figure 2) following DTDP treatments (N2BA: 80±1%, 71±1%, 64±1%, for 
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the first three age groups, respectively; N2B: 74±1%, 62±2%, 53±2%, 32±2%,; for the four 
age groups, respectively, n=10-16 hearts, P<0.05) (C), and panel D illustrates the 
carbonylation indices (CI=1, intesities of all bands were compared with those of the controls 
on the same membranes) following Fenton treatments (N2BA: 2.57±0.06 AU, 2.34±0.04 AU, 
1.35±0.03 AU, for the first three age groups, respectively; N2B: 2.9±0.1 AU, 2.58±0.04 AU, 
1.74±0.04 AU, 1.53±0.05 AU for the four age groups, respectively; P<0.05, n=9-16 hearts) 
(Figure 4) with ageing. Data are means±SEM, and asterisks illustrate significant differences 
vs. data at 0-day-old cardiomyocytes (control) in all graphs. Biochemical data of N2B titin 
isoforms could be analyzed in adult rat cardiomyocytes only. 
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Highlights 
 
 
· Oxidative sensitivity of Fpassive gradually declines with cardiomyocytes age 
· The susceptibilities of N2BA and N2B titin isoforms for oxidative modifications are 
similar at a given cardiomyocyte age 
· The expression levels of myofibrillum associated sHSPs increase gradually in the 
developing heart 
· sHSPs may confer protection against oxidative titin modifications 
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